Gabriela Sanchez

Gabriela Sanchez

Auto-generated profile, based on publicly available information

Gabriela Sanchez

Sección Inmunogenética, Laboratorio de Fisiopatología, Centro de Medicina Experimental. Instituto Venezolano de Investigaciones Científicas, Altos de Pipe, Edo, Apto 1020, Miranda, Venezuela

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Annals of Epidemiology
Verified
Journal Article
Closed access
CICarlos Iribarren
Carlos Iribarren
GSGabriela Sanchez
Gabriela Sanchez
GHGail Husson
Gail Husson
TLTory Levine-Hall
Tory Levine-Hall
CQCharles Quesenberry
Charles Quesenberry
SMSabee Molloi
Sabee Molloi

10 March 2022 in Experimental Parasitology
Verified
Journal Article
Closed access
GSGabriela Sánchez
Gabriela Sánchez
ESEva Salazar-Alcalá
Eva Salazar-Alcalá
FHFernando Hernández
Fernando Hernández
PDPierre-Antoine Deglesne
Pierre-Antoine Deglesne
ZBZoraida Díaz Bello
Zoraida Díaz Bello
MMMercedes Fernandez Mestre
Mercedes Fernandez Mestre

1 June 2021 in Journal of Women's Health
Verified
Journal Article
Open access
CICarlos Iribarren
Carlos Iribarren
MCMalini Chandra
Malini Chandra
SMSabee Molloi
Sabee Molloi
GSGabriela Sanchez
Gabriela Sanchez
FAFatemeh Azamian-Bidgoli
Fatemeh Azamian-Bidgoli
KYKristine Yaffe
Kristine Yaffe
Background: Since vascular risk factors are implicated in cognitive decline, and breast arterial calcification (BAC) is related to vascular risk, we postulated that BAC may be associated with cognitive impairment and dementia. Methods: We used a multiethnic cohort of 3,913 asymptomatic women 60–79 years of age recruited after mammography screening at a large health plan in 2012–2015. A BAC mass score (mg) was derived from digital mammograms. Cognitive function was measured at baseline using the Montreal Cognitive Assessment (MoCA) and incident all-cause dementia (n = 49 events; median follow-up = 5.6 years) were ascertained with validated ICD-9 and ICD-10 codes. We used cross-sectional linear regression of MoCA scores on BAC, then multinomial logistic regression predicting mild cognitive impairment not progressing to dementia and incident all-cause dementia and, finally, Cox regression of incident all-cause dementia. Results: No association by linear regression was found between MoCA scores and BAC presence in unadjusted or adjusted analysis. Women with severe (upper tertile) BAC had a MoCA score lower by 0.58 points (standard error [SE] = 0.18) relative to women with no BAC. However, this difference disappeared after multivariate adjustment. No significant associations were found in multinomial logistic regression for either BAC presence or gradation in unadjusted or adjusted analysis. No significant associations were found between BAC presence with incident all-cause dementia (fully adjusted hazard ratio = 0.74; 95% confidence interval: 0.39–1.39). Likewise, no significant association with incident all-cause dementia was noted for BAC gradation. Conclusions: Our results do not support the hypothesis that BAC presence or gradation may contribute to cognitive impairment or development of all-cause dementia.